Overall rank by patents
#17,453
of 49,997 tracked assignees
USPTO PatentsView assignee record - 16 granted patents across 10 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B67B (Applying Closure Members TO Bottles Jars, OR Similar CONTAINERS; Opening Closed Containers).
The verdict
According to USPTO PatentsView, Arol ranks #17,453 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 10 technology areas.
USPTO PatentsView assignee plate
Corpus R17453 · Foreign Corporation #17,453 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Aptar Stelmi SAS (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Arol S P A · this assignee
34 score
3D Lighting… · lowest
7 score
What this shows Arol's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Arol S.P.A. is a focused PatentsView assignee: 10 CPC subclasses with 75% of grants classified under B67B (Applying Closure Members TO Bottles Jars, OR Similar CONTAINERS; Opening Closed Containers). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2017. By volume, Arol sits between Aptar Stelmi SAS and Aska Pharmaceutical Co., Ltd..
Arol S.P.A. shows 5 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Aptar Stelmi SAS
16 patents
Aradigm Corporation
16 patents
Architectural Builders Hardware MFG., Inc.
16 patents
Arjuna Natural Private Limited
16 patents
ART, Ltd.
16 patents
Asahi Denso Co., Ltd.
16 patents
Aselta Nanographics
16 patents
Aska Pharmaceutical Co., Ltd.
16 patents
Arol S.P.A.
16 patents
What this shows Arol holds 16 patents at rank #17,424, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #17,424 in granted patent volume.
Other assignees with the most granted patents in Arol's primary technology class.
Arol's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 45th percentile higher than 45% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 18.8% |
| 2017 | 1 | 6.3% |
| 2019 | 1 | 6.3% |
| 2021 | 5 | 31.3% |
| 2022 | 4 | 25.0% |
| 2024 | 1 | 6.3% |
| 2025partial year | 1 | 6.3% |
Top 10 of 10 technology areas
Overall rank by patents
#17,453
of 49,997 tracked assignees
33.7 out of 100
What to do with this data
Arol S.P.A.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.